alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro
/in Hepatocellular Carcinoma, International Publications /von 2007-02-21 / Hum. Immunol. 2007 May;68(5):334-41A study of dendritic and endothelial cell interactions in colon cancer in a cell line and small mammal model
/in Colorectal Cancer, International Publications /von 2007-02-20 / Eur J Surg Oncol 2007 Dec;33(10):1191-8Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion
/in Breast Cancer, Dendritic Cells, International Publications /von 2007-02-09 / Cancer Res 2007 Feb;67(4):1842-52Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers
/in Breast Cancer, Dendritic Cells, International Publications /von 2007-02-07 / Cancer Immunol Immunother 2007 Sep;56(9):1485-99[Malignant peritoneal mesothelioma. Our experienced with triple combined therapy: cytoreduction, intraperitoneal perioperative chemotherapy and hyperthermia]
/in Hyperthermia, International Publications, Malignant Pleural Mesothelioma /von 2007-02-01 / Cir Esp 2007 Feb;81(2):82-6Generation of functional dendritic cells (DC) in adult acute lymphoblastic leukemia: rationale for a DC-based vaccination program for patients in complete hematological remission
/in Acute Leukemia, Dendritic Cells, International Publications, Malignant Lymphoma /von 2007-02-01 / Leuk. Lymphoma 2007 Feb;48(2):302-10Dendritic cell vaccine strategies for renal cell carcinoma
/in Hypernephroma, International Publications /von 2007-02-01 / Expert Opin Biol Ther 2007 Feb;7(2):221-32A dendritic cell-based vaccine for treating HIV infection: background and preliminary results
/in HIV/AIDS, International Publications /von 2007-02-01 / J. Intern. Med. 2007 Feb;261(2):123-31Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)-expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice
/in Colorectal Cancer, International Publications /von 2007-02-01 / Int. J. Cancer 2007 Feb;120(3):585-93
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution